Catherine Bergeron

8.1k total citations · 2 hit papers
58 papers, 5.6k citations indexed

About

Catherine Bergeron is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Catherine Bergeron has authored 58 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 19 papers in Physiology and 15 papers in Neurology. Recurrent topics in Catherine Bergeron's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Alzheimer's disease research and treatments (16 papers) and Neurological diseases and metabolism (14 papers). Catherine Bergeron is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Alzheimer's disease research and treatments (16 papers) and Neurological diseases and metabolism (14 papers). Catherine Bergeron collaborates with scholars based in Canada, United States and United Kingdom. Catherine Bergeron's co-authors include Stephen J. Kish, Michael S. Pollanen, Anthony E. Lang, Dennis W. Dickson, Julie M. Wilson, Frank Mastrogiacomo, Andréa C. LeBlanc, Peter St George‐Hyslop, Patrick Horne and David Westaway and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Catherine Bergeron

55 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

2000 1.2k citations Paul M. Mathews, Stephen D. Schmidt et al. profile →
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1996 627 citations Catherine Bergeron, Stephen J. Kish et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Bergeron Canada	31	2.5k	2.0k	1.8k	1.4k	1.1k	58	5.6k
Marie‐Christine Chartier‐Harlin France	35	2.8k 1.1×	2.3k 1.2×	1.8k 1.0×	2.7k 1.9×	938 0.9×	88	6.0k
T Saitoh United States	32	3.1k 1.3×	2.1k 1.1×	1.7k 1.0×	1.6k 1.2×	697 0.6×	49	5.1k
Jordi Pérez‐Tur Spain	37	3.5k 1.4×	2.2k 1.1×	1.3k 0.7×	1.7k 1.2×	994 0.9×	91	5.6k
B. T. Hyman United States	18	2.7k 1.1×	1.9k 1.0×	1.4k 0.8×	920 0.6×	922 0.9×	33	5.2k
Yasuji Matsuoka United States	40	3.2k 1.3×	2.4k 1.2×	1.4k 0.8×	688 0.5×	1.1k 1.0×	80	5.9k
Takeshi Kawarabayashi Japan	31	4.1k 1.7×	2.2k 1.1×	1.3k 0.7×	645 0.5×	1.0k 0.9×	129	5.7k
David Nochlin United States	45	4.0k 1.6×	3.0k 1.5×	1.2k 0.7×	1.5k 1.0×	1.2k 1.1×	92	6.6k
Emmanuel Planel Canada	47	3.6k 1.4×	2.4k 1.2×	1.9k 1.1×	840 0.6×	897 0.8×	92	6.6k
Nicolas Sergeant France	51	4.2k 1.7×	3.7k 1.9×	2.2k 1.2×	1.4k 1.0×	1.3k 1.2×	126	7.8k
Laurent Pradier France	39	2.9k 1.2×	2.6k 1.3×	1.8k 1.0×	575 0.4×	777 0.7×	98	5.2k

Countries citing papers authored by Catherine Bergeron

Since Specialization

Citations

This map shows the geographic impact of Catherine Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Bergeron more than expected).

Fields of papers citing papers by Catherine Bergeron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Bergeron. The network helps show where Catherine Bergeron may publish in the future.

Co-authorship network of co-authors of Catherine Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Bergeron. A scholar is included among the top collaborators of Catherine Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Bergeron. Catherine Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cerny, Milena, Damien Olivié, Jean-Sébastien Billiard, et al.. (2018). LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Abdominal Radiology. 44(2). 517–528. 30 indexed citations

Cerny, Milena, Catherine Bergeron, Jean-Sébastien Billiard, et al.. (2018). LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features. Radiology. 288(1). 118–128. 101 indexed citations

Hazrati, Lili‐Naz, Catherine Bergeron, & Jagdish Butany. (2009). Neuropathology of cerebrovascular diseases. Seminars in Diagnostic Pathology. 26(2). 103–115. 7 indexed citations

Hazrati, Lili‐Naz & Catherine Bergeron. (2008). Neuropathology and genetics of corticobasal degeneration. Handbook of clinical neurology. 89. 523–532. 2 indexed citations

Nguyen, Van Dan, Cynthia Hawkins, Catherine Bergeron, et al.. (2006). Loss of nicastrin elicits an apoptotic phenotype in mouse embryos. Brain Research. 1086(1). 76–84. 23 indexed citations

Larue, Sandrine, Steve Verreault, Peter V. Gould, et al.. (2006). A Case of Familial Creutzfeldt-Jakob Disease Presenting with Dry Cough. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 33(2). 243–245. 4 indexed citations

Guo, Hui‐Shan, et al.. (2004). Active Caspase-6 and Caspase-6-Cleaved Tau in Neuropil Threads, Neuritic Plaques, and Neurofibrillary Tangles of Alzheimer's Disease. American Journal Of Pathology. 165(2). 523–531. 237 indexed citations

Phinney, Amie L., et al.. (2003). Mouse models of Alzheimer's disease: The long and filamentous road. Neurological Research. 25(6). 590–600. 35 indexed citations

Fox, Susan H., et al.. (2003). Pure cerebello‐olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea. Movement Disorders. 18(12). 1550–1554. 5 indexed citations

10.

Muñoz, David G., Dennis W. Dickson, Catherine Bergeron, et al.. (2003). The neuropathology and biochemistry of frontotemporal dementia. Annals of Neurology. 54(S5). S24–S28. 65 indexed citations

11.

Rozmahel, Richard, Howard T.J. Mount, Fusheng Chen, et al.. (2002). Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype. Proceedings of the National Academy of Sciences. 99(22). 14452–14457. 15 indexed citations

12.

Grimes, David A., Catherine Bergeron, & Anthony E. Lang. (1999). Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Movement Disorders. 14(4). 674–680. 44 indexed citations

13.

Bergeron, Catherine, et al.. (1998). Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline. Brain Pathology. 8(2). 355–365. 73 indexed citations

14.

Bergeron, Catherine, et al.. (1994). Le Grand Louvre : histoire d'un projet.

15.

Bergeron, Catherine, et al.. (1994). Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons. Journal of Neuropathology & Experimental Neurology. 53(3). 221–230. 134 indexed citations

16.

Mastrogiacomo, Frank, Catherine Bergeron, & Stephen J. Kish. (1993). Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease. Journal of Neurochemistry. 61(6). 2007–2014. 149 indexed citations

17.

Pollanen, Michael S., Catherine Bergeron, & Luitgard Weyer. (1993). Deposition of detergent-resistant neurofilaments into Lewy body fibrils. Brain Research. 603(1). 121–124. 23 indexed citations

18.

Morrison, Lesley D., Catherine Bergeron, & Stephen J. Kish. (1993). Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease. Neuroscience Letters. 154(1-2). 141–144. 18 indexed citations

19.

Somerville, Martin J., et al.. (1991). Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in alzheimer brains. Molecular Brain Research. 9(1-2). 1–8. 49 indexed citations

20.

Perry, Thomas L., et al.. (1989). β-N-Methylamino-l-alanine. Journal of the Neurological Sciences. 94(1-3). 173–180. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact